Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy

BACKGROUND: The safety and efficacy of low-sodium oxybate (LXB; Xywav(®)) were established in a randomized, double-blind, placebo-controlled, phase 3 withdrawal study in adults with narcolepsy with cataplexy; however, the longer-term safety profile has not yet been examined. The aim of the current a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogan, Richard K., Foldvary-Schaefer, Nancy, Skowronski, Roman, Chen, Abby, Thorpy, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126024/
https://www.ncbi.nlm.nih.gov/pubmed/36947322
http://dx.doi.org/10.1007/s40263-023-00992-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126024/
https://www.ncbi.nlm.nih.gov/pubmed/36947322
http://dx.doi.org/10.1007/s40263-023-00992-y

Ejemplares similares